Ingersoll Rand Inc. (IR) News
Track canonical SquawkNews coverage tagged to IR, Ingersoll Rand Inc.. This hub brings together deduplicated headlines about united states, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 22 indexed stories across 10 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
IR - Ingersoll Rand to Participate in Upcoming Investor Conferences
IR - Ingersoll Rand to Participate in Upcoming Investor Conferences
EQUITY | Aug 26, 2026, 08:36 PM UTC
L
Ingersoll Rand to participate in investor conferences
Ingersoll Rand plans to participate in upcoming investor conferences.
EQUITY | Aug 26, 2026, 08:30 PM UTC
L
CGON remain constructive on CGON ahead of the Ph3 PIVOT-006 pivotal data in IR NMIBC @ UBS
CGON remain constructive on CGON ahead of the Ph3 PIVOT-006 pivotal data in IR NMIBC @ UBS
EQUITY | Aug 20, 2026, 11:06 AM UTC
M
IR shares fall for 9th straight day below 200dma support
IR stock is down 1% to $81.40 for a ninth straight day, after slipping below 200dma support at $81.95 while holding just above 50dma support at $81.15.
EQUITY | Aug 18, 2026, 03:18 PM UTC
L
Multiple Stocks Trade Ex-Dividend
Several stocks trade ex-dividend on Thursday, August 13
EQUITY | Aug 12, 2026, 08:35 PM UTC
L
Multiple Stocks Go Ex-Dividend On Aug 13
Several stocks go ex-dividend on Thursday, August 13, including TJX, FIX, and FANG
EQUITY | Aug 12, 2026, 03:06 PM UTC
H
Insiders Buy $13M+ in BSX, HLI, IR, PFE, WCC, TLSA, TSCO
Insiders purchase over $13 million in company shares
EQUITY | Aug 06, 2026, 09:19 AM UTC
M
Ingersoll Rand Acquires Lone Star Blower
Ingersoll Rand expands blower technologies and services
MNA | Aug 03, 2026, 12:04 PM UTC
H
Stifel Upgrades IR to Buy
Stifel upgrades IR to Buy with $84 target
EQUITY | Aug 03, 2026, 11:48 AM UTC
H
Ingersoll-Rand upgraded to Buy at Stifel
Ingersoll-Rand upgraded to Buy with $101 target
EQUITY | Aug 03, 2026, 11:05 AM UTC
H
Analysts Upgrade COUR, ETN, IR, LYB, SBUX
Multiple stocks upgraded by analysts
EQUITY | Aug 03, 2026, 10:57 AM UTC
H
Ingersoll Rand Sees FY2026 Revenue Growth
Ingersoll Rand forecasts revenue growth
EARNINGS | Jul 30, 2026, 08:36 PM UTC
H
Ingersoll Rand Q2 EPS Beats Estimates
Ingersoll Rand beats Q2 EPS estimates
EARNINGS | Jul 30, 2026, 08:34 PM UTC
H
IR - Ingersoll Rand Reports Second Quarter 2026 Results
IR - Ingersoll Rand Reports Second Quarter 2026 Results
EARNINGS | Jul 30, 2026, 08:20 PM UTC
H
Ingersoll Rand Raises FY2026 Adj EPS Guidance from $3.45-$3.57 to $3.57 vs $3.50 Est; Raises FY2026 Sales Guidance from $7.842B-$7.995B to $
Ingersoll Rand (NYSE: IR ) raises FY2026 Adj EPS guidance from $3.45-$3.57 to $3.57 vs $3.50 analyst estimate. Raises FY2026 sales outlook from $7.842 billion-$7.995 billion to $7.995 billion-$8.148 billion vs $7.941 bil
EARNINGS | Jul 30, 2026, 08:18 PM UTC
H
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
MYGN -29%, RBLX -11.6%, FLGT -10.7%, VCYT -9.8%, SYK -9.5%, ALHC -8.6%, COIN -6.5%, RDDT -5.8%, GSIT -5.3%, IR -3.1% after results
EARNINGS | Jul 30, 2026, 08:15 PM UTC
H
IR Ingersoll Rand RESULTS: Q2, Q2 REV $2,048.8M vs. EST $1.959B, Q2 Operating Income $380.3M, Q2 pretax profit $327.1M, Q2 gross profit $862
IR Ingersoll Rand RESULTS: Q2, Q2 REV $2,048.8M vs. EST $1.959B, Q2 Operating Income $380.3M, Q2 pretax profit $327.1M, Q2 gross profit $862.6M, Q2 EPS $0.66, Q2 Net Income $258M, Q2 ADJ EBITDA $520M
EARNINGS | Jul 30, 2026, 08:10 PM UTC
H
Implied EPS movers for tonight: AAPL +/-3.5%, AMZN +/-5.8%, MPWR +/-15.1%, MSTR +/-5.4%, COIN +/-6.8%, SYK +/-7.2%, RDDT +/-9.8%, DXCM +/-7.
Implied EPS movers for tonight: AAPL +/-3.5%, AMZN +/-5.8%, MPWR +/-15.1%, MSTR +/-5.4%, COIN +/-6.8%, SYK +/-7.2%, RDDT +/-9.8%, DXCM +/-7.5%, RIVN +/-7.9%, NXT +/-16.8%, MTZ +/-14.6%, AJG +/-7.2%, GH +/-14.1%, CTVA +/-
EARNINGS | Jul 30, 2026, 05:58 PM UTC
L
Near 200dma resistance CRUS PHM ELF IR THC WBD
Near 200dma resistance CRUS PHM ELF IR THC WBD
EQUITY | Jul 21, 2026, 05:49 PM UTC
L
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
If approved, deucrictibant will be the first oral bradykinin B2 receptor antagonist to tre
REGULATION | Jul 06, 2026, 10:50 AM UTC
L
Element 29 Renews IR Consultant Agreement and Engages Market Maker
2026-07-03 05:30:00 ET
EQUITY | Jul 03, 2026, 02:29 PM UTC
L
Element 29 Renews IR Consultant Agreement and Engages Market Maker
Vancouver, British Columbia--(. - July 3, 2026) - Element 29 Resources Inc. (TSXV: ECU) (OTCQB: EMTRF) (BVL: ECU) ("Element 29" or the "Company") today announced it
EQUITY | Jul 03, 2026, 11:31 AM UTC